HillSignal

TICKER INTELLIGENCE

$GHRS

Company & Legislative Profile

$GHRS is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $GHRS, including 1 bill. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.

$GHRS is currently facing 1 active congressional signal tracked by HillSignal. With 1 bullish, and 0 bearish signal, the average legislative impact score is 5.0/10. Key sectors affected include Healthcare. Recent major catalysts include Freedom to Heal Act of 2025. Below is the complete tracker of government activity affecting $GHRS’s market performance.

1

Total Signals

5.0/10

Avg Impact

1

Bullish Signals

0

Bearish Signals

Related Sectors

Healthcare

Recent Congressional Signals for $GHRS

Freedom to Heal Act of 2025

BULLISH

The Freedom to Heal Act of 2025 establishes a special registration process for physicians to administer Schedule I investigational drugs to eligible patients under the Right to Try law. This directly expands access to psychedelic and other Schedule I investigational therapies, accelerating their development and patient use. Companies developing these therapies will see increased market access and potential revenue streams.

Impact: 5/10(Committee action)HR6434Congressional Bill

Understanding These Signals

What is a Signal?Impact ScoreMarket SentimentFederal ContractsFull Glossary →

Get Full Access to $GHRS Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Become a Member →